MD SB688 | 2022 | Regular Session

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 4 2022 - 25% progression, died in committee
Action: 2022-02-08 - Hearing 2/23 at 1:00 p.m.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Establishing certain requirements on utilization review of prescription drug and device coverage by health insurers, nonprofit health service plans, and health maintenance organizations; providing that a denial of coverage for a prescription drug or device made during the course of utilization review is eligible for an expedited appeal under certain circumstances; etc.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health Insurance - Utilization Review for Coverage of Prescription Drugs and Devices - Expedited Appeals

Sponsors


History

DateChamberAction
2022-02-08SenateHearing 2/23 at 1:00 p.m.
2022-02-04SenateFirst Reading Finance

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
Insurance151012(n/a)See Bill Text

Maryland State Sources


Bill Comments

feedback